- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Caliway Biopharmaceuticals
Market Cap: NT$158.7b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$102.00
7D
-1.9%
1Y
-17.4%
Bora Pharmaceuticals
Market Cap: NT$48.1b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$378.00
7D
-10.6%
1Y
-44.5%
Lotus Pharmaceutical
Market Cap: NT$46.1b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$175.50
7D
-8.8%
1Y
-19.9%
Oneness Biotech
Market Cap: NT$20.3b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$42.25
7D
-11.4%
1Y
-34.7%
TaiMed Biologics
Market Cap: NT$15.4b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$56.50
7D
-3.3%
1Y
-32.5%
Medigen Vaccine Biologics
Market Cap: NT$15.0b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$45.70
7D
-3.9%
1Y
6.0%
EirGenix
Market Cap: NT$13.9b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$45.85
7D
-1.6%
1Y
-28.9%
Foresee Pharmaceuticals
Market Cap: NT$12.4b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$79.00
7D
-4.8%
1Y
7.3%